• 1. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 2. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 3. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 4. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 5. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Carboxylic acid derivatives Carboxylic acid hydrazides

Research Brief on 3-Hydroxy-2-methylpropanoic acid; (S)-form, Hydrazide (CAS: 26543-06-6)

In recent years, the compound 3-Hydroxy-2-methylpropanoic acid; (S)-form, Hydrazide (CAS: 26543-06-6) has garnered significant attention in the field of chemical biology and pharmaceutical research. This chiral hydrazide derivative, characterized by its (S)-configuration, has shown promising potential in various applications, including drug synthesis, enzyme inhibition, and as a building block for more complex bioactive molecules. The unique structural features of this compound, particularly the presence of both hydroxy and hydrazide functional groups, make it a versatile intermediate in medicinal chemistry.

Recent studies have focused on the synthesis and optimization of 3-Hydroxy-2-methylpropanoic acid; (S)-form, Hydrazide to enhance its yield and purity. Advanced techniques such as asymmetric catalysis and enzymatic resolution have been employed to achieve high enantiomeric excess (ee) of the (S)-form, which is crucial for its biological activity. Researchers have also explored its role in the development of novel hydrazide-based inhibitors targeting key enzymes involved in metabolic disorders and infectious diseases.

One of the most notable applications of this compound is its use as a precursor in the synthesis of peptidomimetics and other bioactive molecules. The hydrazide moiety allows for efficient conjugation with various pharmacophores, enabling the design of compounds with improved pharmacokinetic properties. For instance, recent work has demonstrated its utility in the development of protease inhibitors, where the (S)-configuration is essential for binding affinity and selectivity.

In addition to its synthetic applications, 3-Hydroxy-2-methylpropanoic acid; (S)-form, Hydrazide has been investigated for its potential as a chiral auxiliary in asymmetric synthesis. Its ability to induce stereoselectivity in reactions has been leveraged to produce enantiomerically pure compounds, which are highly valuable in pharmaceutical manufacturing. Furthermore, its stability under physiological conditions makes it an attractive candidate for in vivo studies.

Despite these advancements, challenges remain in the large-scale production and application of this compound. Issues such as cost-effective synthesis, scalability, and environmental impact need to be addressed to fully realize its potential. Ongoing research aims to develop greener synthetic routes and explore novel derivatives with enhanced bioactivity.

In conclusion, 3-Hydroxy-2-methylpropanoic acid; (S)-form, Hydrazide (CAS: 26543-06-6) represents a valuable tool in chemical biology and drug discovery. Its unique structural properties and versatile applications underscore its importance in the development of next-generation therapeutics. Future studies should focus on optimizing its synthesis, expanding its utility, and addressing current limitations to unlock its full potential in the pharmaceutical industry.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)